Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- H.C. Wainwright lowered the price target on Eloxx Pharmaceuticals Inc (NASDAQ:ELOX) to $1 from $2 and reiterated a Neutral rating.
- Analyst Andrew Fein says the ELX-02 top-line data "raises more questions than answers."
- Despite the "seemingly positive narrative put forward for the top-line data from ELX-02's Phase 2 top-line readout, we remain unconvinced," Fein tells investors in a research note.
- Related Link: Eloxx Shares Slump As Phase 2 Cystic Fibrosis Trial Data Fails To Cheer Investors.
- Price Action: ELOX shares are down 12.40% at $0.76 during the market session on the last check Thursday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!